Translational Cancer Research

Papers
(The TQCC of Translational Cancer Research is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Successful treatment with osimertinib for nonmucinous bronchioloalveolar carcinoma with massive bronchorrhea and respiratory failure: a case report and literature review47
A prognostic nomogram based on least absolute shrinkage and selection operator Cox regression in patients with pulmonary large-cell neuroendocrine carcinoma42
LncRNA RP11-10E18.7 cooperates with lncRNA RP11-481C4.2 to affect the overall survival of breast cancer patients: a TCGA-based retrospective study36
Advanced non-small cell lung cancer treated with palliative systemic therapy complicated by calvarial metastasis: a case report30
Molecular basis of heterogeneity in small cell lung cancer28
First-line therapy for recurrent metastatic head and neck squamous cell carcinoma: every rose has its thorn25
Comprehensive analysis of exosome gene LYPD3 and prognosis/immune cell infiltration in lung cancer23
Clinical pathological characteristics correlation of H3F3A gene mutation in giant cell tumor of bone: a study of 96 cases23
Efficacy of second- and third-line chemotherapy after chemotherapy with platinum doublet and immunotherapy in non-small cell lung cancer: a descriptive study23
Efficacy, safety and pharmacokinetics of apatinib plus etoposide versus apatinib alone for platinum-resistant recurrent ovarian cancer: protocol of a multicenter, open-label, randomized phase 2 trial21
The efficacy and safety of apatinib in patients with heavily pretreated end-stage cancer: a retrospective study20
Genome-wide profiling of a prognostic RNA-binding protein signature in esophageal cancer20
Prognostic significance of B cell senescence-associated genes as risk markers in prostate adenocarcinoma19
Establishment and validation of a prognostic prediction model for glioma based on key genes and clinical factors19
Combining Bulk RNA-seq and scRNA-seq data to identify RNA m5C methyltransferases NSUN1: a rising star as a biomarker for cancer diagnosis, prognosis and therapy18
Immunogenomic classification and nomogram development and validation for colorectal cancer survival prediction based on immune-related genes18
Effect of caspase-1 (CASP1) combined with multimodal ultrasound features on the prognosis of breast cancer patients18
Association of branched-chain amino acids and risk of three urologic cancers: a Mendelian randomization study18
Incorporating host genetics and inflammation in myelosuppression risk prediction for triple-negative breast cancer18
Diagnostic value of double low-dose targeted perfusion CT imaging for the diagnosis of invasive and preinvasive pulmonary ground-glass nodules: systematic review and meta-analysis17
Identification of tumor antigens for mRNA vaccines and ferroptosis-related landscape in esophageal squamous cell carcinoma17
Immunotherapy for combined pulmonary fibrosis and emphysema with advanced lung cancer: two case reports and a concise review17
Neoadjuvant therapy bridging percutaneous coronary intervention (PCI) and video-assisted thoracoscopic (VATS) lobectomy: a retrospective study17
Key considerations for interpreting patient-reported outcomes in deep inferior epigastric artery perforator flap reconstruction with post-mastectomy radiotherapy16
Construction of a prognostic model for lung adenocarcinoma based on necroptosis genes and its exploration of the potential for tumor immunotherapy16
A STEP ahead for CAR-T cell therapy of large B cell lymphoma: understanding the molecular determinants of resistance16
Construction of molecular subtypes and prognostic model for breast cancer based on sulfur metabolism-related genes16
Gastric cancer prognosis: unveiling autophagy-related signatures and immune infiltrates16
Effects of p-cresol, a uremic toxin, on cancer cells15
Identification of neuronal synapse-related signatures and potential therapeutic drugs in colorectal cancer based on machine learning algorithms and molecular docking15
Development and validation of a prognosis model for patients with brain-metastasis non-small cell lung cancer by machine-learning15
The association between ephrin receptor-A1 expression and survival in patients with cancer: a meta-analysis15
Unveiling prognostic factors and predictive modeling in lung adenocarcinoma with neuroendocrine differentiation15
Does circulating DNA tumor fraction add value to prostate-specific antigen in metastatic castration-resistant prostate cancer?15
CLCN3 in mediating the proliferation of human ovarian cancer cells14
An E7-retinoblastoma protein pathway mechanism may account for the higher carcinogenic ability of HPV16 over HPV58 in cervical cancer14
Development and validation of a clinical diagnostic model for surgical site infection after surgery in patients with gastric cancer14
PTPMT1 inhibition induces apoptosis and growth arrest of human SCLC cells by disrupting mitochondrial metabolism14
Utilization of intraoperative indocyanine green fluorescence imaging to identify vascular anatomy in severe pleural adhesions in uniportal video-assisted thoracoscopic surgery: a case report14
Focal pyroptosis-related genes AIM2 and ZBP1 are prognostic markers for triple-negative breast cancer with brain metastases13
Liver-directed moderately hypo-fractionated radiotherapy combined with pembrolizumab and bevacizumab for advanced hepatocellular carcinoma: a retrospective observational study of 23 cases13
miR-137 represses migration and cell motility by targeting COX-2 in non-small cell lung cancer13
Clusterin is a biomarker of breast cancer prognosis and correlated with immune microenvironment13
A novel signature based on autophagy-related lncRNA for prognostic prediction and candidate drugs for lung adenocarcinoma13
OIP5-AS1/miR-455-3p/microfibril-associated protein 2 axis exacerbates the progression of thyroid carcinoma13
Research progress in predicting visceral pleural invasion of lung cancer: a narrative review13
A circadian clock gene-related signature for predicting prognosis and its association with sorafenib response in hepatocellular carcinoma12
Identification of novel candidate genes and small molecule drugs in ovarian cancer by bioinformatics strategy12
The prognostic value and mechanisms of centromere protein M in patients with lung adenocarcinoma12
A systematic review and meta-analysis of the effects of muscle relaxation training vs. conventional nursing on the depression, anxiety and life quality of patients with breast cancer12
TOP2A promotes non-small cell lung cancer progression via LDHA-mediated glycolysis and histone lactylation12
Adagrasib in the treatment of KRASG12C-mutated non-small cell lung cancer: a cost-effectiveness analysis12
Treatment of immune checkpoint inhibitor-related colitis: a narrative review12
The size and sternal involvement of chest wall resections for malignant disease predict postoperative morbidity11
Characteristics of lung cancer screening eligible population in the US and prediction of the eligibility with simplified criteria11
ECSIT inhibits cell death to increase tumor progression and metastasis via p53 in human breast cancer11
Prognostic development and validation of a prediction model based on major histocompatibility complex-related differentially expressed genes in stomach adenocarcinoma11
MiR-193b as an effective biomarker in human cancer prognosis for Asian patients: a meta-analysis11
Three-dimensional model to simulate esophagectomy in patients with a mediastinal vascular anomaly: to see is to believe11
Construction of a prognostic signature for breast cancer based on genes involved in unsaturated fatty acid biosynthesis11
A narrative review of papillary thyroid carcinoma-related long non-coding RNAs and their relevance to malignant tumors11
Novel cuproptosis-related lncRNAs can predict the prognosis of patients with multiple myeloma11
Distribution characteristics and prognosis of tumor-infiltrating lymphocytes in the brain metastases of small cell lung cancer: a retrospective cohort study11
The association of tumor diameter with lymph node metastasis and recurrence in patients with endometrial cancer: a systematic review and meta-analysis11
Analysis and assessment of ferroptosis-related gene signatures and prognostic risk models in skin cutaneous melanoma10
Advances in genomic biomarkers for lethal metastatic castration-resistant prostate cancer10
Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy for resectable esophageal cancer: a systematic review and meta-analysis10
Oncologic and obstetric outcomes of a novel nerve-sparing radical trachelectomy while preserving the uterine branches of the pelvic nerves10
The mechanism and research progress of PD-1/PD-L1 on immune escape of lung cancer10
Telomere-related gene risk model for prognosis prediction in colorectal cancer10
A novel inflammatory nutrient index for predicting survival outcomes in patients with non-small cell lung cancer10
The predictive value of HER2DX assay with pathological response and prognosis in patients with early HER2-positive breast cancers: commentary on the PHERGain trial10
ATP5A1 as a potential prognostic biomarker in clear-cell renal cell carcinoma10
Osimertinib-chemotherapy synergy in EGFR-mutant NSCLC: advancing central nervous system control amidst toxicity considerations10
Association between human epidermal growth factor receptor 2 status, namely low and zero expression, and prognosis in hormone receptor-positive breast cancer: a single-center retrospective study9
Study on the prevalence and subtypes of human papillomavirus infection among women in the Xuhui District, Shanghai City, China9
The pan-cancer landscape of crosstalk between leukocyte transendothelial migration-related genes and tumor microenvironment relevant to prognosis and immunotherapy response9
Value of ZSCAN9 in the treatment and survival prediction of hepatocellular carcinoma: a bioinformatics study9
Problems and countermeasures for surgical resection of primary pulmonary artery intimal sarcoma9
Overexpression of SPHK1 associated with targeted therapy resistance in predicting poor prognosis in renal cell carcinoma9
Association between unintentional splenic radiation and lymphopenia and high neutrophil/lymphocyte ratio after radiotherapy in patients with esophageal cancer9
Experience with flap repair after vulvar carcinoma resection: a retrospective observational study of 26 cases9
Development and validation of nomogram-based models for personalized survival assessment in pediatric hepatoblastoma patients9
CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy9
Cuproptosis-related molecular classification and gene signature of hepatocellular carcinoma and experimental verification9
EPB41L4A-AS1 regulates cervical cancer by proliferative cells: mendelian randomization and single-cell transcriptomics analyses9
Development and validation of a nomogram for predicting overall survival in patients with stage III-N2 lung adenocarcinoma based on the SEER database9
DNMT3A promotes glioma growth and malignancy via TNF-α/NF-κB signaling pathway9
Undifferentiated embryonic sarcoma of the adult liver with paraneoplastic syndrome: a case report9
Allogeneic CAR-T bridging to allo-HSCT as a treatment strategy for refractory adult Burkitt’s lymphoma: a case report9
Integrated analysis of coexpression and a tumor-specific ceRNA network revealed a potential prognostic biomarker in breast cancer9
Efficacy, cardiotoxicity and factors affecting pathologic complete response of neoadjuvant chemotherapy with anthracycline-containing verses anthracycline-free regimens plus dual HER2 blockade for HER9
A newly identified pyroptosis-related gene signature for predicting prognosis of patients with hepatocellular cancer9
IL-6 promotes metastasis and EMT of non-small cell lung cancer cells by up-regulating FGL1 via STAT3 pathway9
Primary malignant pericardial mesothelioma with a survival of 2.5 years: a case report9
Stemness-hypoxia genes PPARGC1A, PFKFB3, and SLC2A5 are associated with prognosis and tumor immune microenvironment in hepatocellular carcinoma9
Histone methyltransferase KMT2D mediated lipid metabolism via peroxisome proliferator-activated receptor gamma in prostate cancer9
Intertumoral disulfidptosis heterogeneity in triple-negative breast cancer, a multiomics integration analysis9
Cytoreductive partial and radical nephrectomies provide equivalent oncologic outcomes in T1–2M1 renal cell carcinoma9
Erratum to lncRNA FAM66C inhibits pancreatic cancer progression by sponging miR-574-3p8
Construction of a prognosis model of head and neck squamous cell carcinoma pyroptosis and an analysis of immuno-phenotyping based on bioinformatics8
Exploring potential causal genetic variants and genes for endometrial cancer: Open Targets Genetics, Mendelian randomization, and multi-tissue transcriptome-wide association analysis8
Circular RNA circTADA2A promotes the proliferation, invasion, and migration of non-small cell lung cancer cells via the miR-450b-3p/HMGN5 signaling pathway8
Prediction of mortality in patients with retinoblastoma based on random survival forest: a retrospective cohort analysis using SEER database8
Prognostic value of preoperative combined with postoperative systemic immune-inflammation index for disease-free survival after radical rectal cancer surgery: a retrospective cohort study8
ThinPrep cytologic test combined with HPV typing to evaluate the degree of cervical diseases and the relationship between HPV typing and the pathological results of patients with atypical squamous cel8
Tumor-treating fields in combination with sorafenib curtails the growth of colorectal carcinoma by inactivating AKT/STAT3 signaling8
B7-H3 promotes proliferation and migration of lung cancer cells by modulating PI3K/AKT pathway via ENO1 activity8
FXR activation suppresses NF-κB signaling, proliferation and migration in cervical cancer cells8
Oncologic outcome of breast reconstruction after mastectomy in breast cancer: a systematic review and meta-analysis8
Increased expression of HBXIP (LAMTOR5) predicts poor prognosis and is correlated with immune-cell infiltration in glioma8
Clarifying the role of adjuvant therapy after multi-agent neoadjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma8
Harnessing natural killer cell-related genes for prognostic and therapeutic advances in lung adenocarcinoma: a predictive model for survival and immunotherapy outcomes8
Granzyme B for predicting the durable clinical benefit of anti-PD-1/PD-L1 immunotherapy in patients with non-small cell lung cancer8
The expression of programmed cell death ligand 1 (PD-L1) involves in the clinicopathologic characteristics and prognostic implications of testicular germ cell tumor (TGCT): a systematic review and met8
Integrative analysis of CRISPR screening and gene expression data identifies a three-gene prognostic model associated with immune microenvironment in neuroblastoma8
Risk factors, prognostic factors and nomograms for distant metastasis in colorectal neuroendocrine neoplasms: a SEER-based study8
Prognostic significance of chemotherapy response score in predicting outcomes for high-grade serous ovarian carcinoma patients undergoing neoadjuvant chemotherapy8
Comparison of the short-term outcomes of open and laparoscopic hepatectomy in the treatment of recurrent hepatocellular carcinoma: a single-center retrospective study8
Uterine intravascular leiomyomatosis involves the heart: a case report and literature review8
Efficacy of relative dose intensity of nab-paclitaxel for the short-term outcomes, survival, and quality of life in patients with advanced pancreatic cancer: a retrospective study8
Patient outcomes after non-curative endoscopic submucosal dissection for early colorectal cancer: a single-center, retrospective cohort study8
Exosomal microRNAs in lung cancer: a narrative review8
High expression of ceramide synthase 5 predicts a poor prognosis in gastric cancer8
Women’s hormonal health research and care: the times, they are a-changin’8
Rationale and design of a prospective, multicenter, cohort study on the evaluation of postoperative Venous ThromboEmbolism incidence in patients with ColoRectal Cancer (CRC-VTE trial)7
Inhibitory effects of LOXL2 knockdown on cellular functions of liver cancer stem cells7
Development and validation of a prognostic predictive model of pulmonary spindle cell carcinoma from the surveillance, epidemiology and end results database7
MicroRNA-125b inhibits apoptosis and increases gemcitabine resistance by downregulating the expression of BAK1 in pancreatic ductal adenocarcinoma7
Slamming hepatocellular carcinoma: targeting immunosuppressive macrophages via SLAMF7 reprograms the tumor microenvironment7
A nomogram for predicting overall survival in advanced hepatocellular carcinoma patients receiving radiotherapy combined with targeted therapy: a multicenter retrospective study7
Optimizing immunotherapy for lung cancer: integrating genetic alterations and the tumor mutational burden to refine patient selection7
The impact of the location, incidence and distribution of lung metastases in primary colorectal and renal cell cancer patients on prognosis: a retrospective observational study7
Comprehensive analysis of disulfidptosis-related lncRNAs for predicting prognosis and response of immunotherapy in pancreatic adenocarcinoma7
Efficacy and regulatory strategies of gut microbiota in immunotherapy: a narrative review7
Comparable prognosis of early gastric cancer between intestinal type and diffuse type in patients of age 75 and older: a SEER-based cohort study7
A prognostic model for laryngeal squamous cell carcinoma based on the mitochondrial metabolism-related genes7
Single-cell analysis revealed a diagnostic model of hepatocellular carcinoma based on cancer stem cell-related gene7
Therapeutic vaccines for human papillomavirus-related cancer: progress and challenges7
Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells7
Effect and mechanism of auranofin on extrusion and migration of breast cancer cells7
Development of a novel colon adenocarcinoma m6A-related lncRNA pair prognostic model7
An immune-related miRNA signature predicts the prognosis in nasopharyngeal carcinoma7
Fusion of NY-ESO-1 epitope with heat shock protein 70 enhances its induced immune responses and antitumor activity against glioma in vitro7
The clinicopathological characteristics and survival outcomes of primary expansile vs. infiltrative mucinous ovarian adenocarcinoma: a retrospective study sharing the experience of a tertiary centre7
Predictive model of gene expression regulating invasion and migration of M2 macrophages in breast cancer: clinical prognosis and therapeutic implications7
Radiomic signatures of brain metastases on MRI: utility in predicting pathological subtypes of lung cancer7
Winning hearts & minds: prostate cancer outreach and clinical trial enrollment in minority men7
The predictive implication of programmed cell death ligand 1 expression in extranodal natural killer/T-Cell lymphoma and its correlation with clinicopathological features: a systematic review and meta7
KIF18A and CDK1 as combined therapeutic targets in cervical and endometrial carcinomas: based on bioinformatics analysis and in vitro experiments7
Construction and validation of four-metabolism related-long non-coding RNAs as potential signature in prognosis of colon cancer7
Prognostic significance of alterations in peripheral cellular and humoral immune biomarkers during radiochemotherapy in head and neck cancer patients7
Comprehensive analysis of tumor immune-related gene signature for predicting prognosis, immunotherapy, and drug sensitivity in bladder urothelial carcinoma7
Survival analysis of gastric malignancy patients: identifying key prognostic factors7
High expression of SETDB1 mediated by miR-29a-3p associates with poor prognosis and immune invasion in breast invasive carcinoma7
Competing risk analysis of cardiovascular death in breast cancer: evidence from the SEER database7
Identification of basement membrane-based prognostic signature and potential therapeutic drugs in hepatocellular carcinoma7
Tackling the HuRdle of radioresistance: a radiation perspective on the RNA-binding protein HuR7
Effect of periplocin on malignant behavior of oral squamous cell carcinoma cells7
Herpes simplex virus-thymidine kinase/ganciclovir suppressed the growth of lung adenocarcinoma cells accompanied by premature senescence7
LncRNA OXCT1-AS1 promotes the proliferation of non-small cell lung cancer cells by targeting the miR-195/CCNE1 axis7
Proteome-wide identification and functional analysis of ubiquitinated proteins in Hepa1-6 cells by knockdown of E3 ubiquitin ligase SIAH17
Identification of hub genes and key modules in laryngeal squamous cell carcinoma7
Durable clinical response to ALK tyrosine kinase inhibitors in ALK-rearranged non-small cell lung cancer: a case report7
Identification of Fanconi anemia pathway genes as novel prognostic biomarkers and therapeutic targets for breast cancer7
Study on the value of multi-dimensional conformal radiotherapy and functional imaging in tumor bioimaging7
A novel mesenchymal epithelial transition (MET) inhibitor, CB538, relieves acquired resistance in EGFR-mutated MET-amplified non-small cell lung cancer7
Expression of copper metabolism-related genes is associated with the tumor immune microenvironment and predicts the prognosis of hepatocellular carcinoma7
Construction of a novel disulfidptosis-associated lncRNAs signature for risk features and immunotherapy in breast cancer6
A potential EBV-related classifier is associated with the efficacy of immunotherapy in gastric cancer6
A signature of four ferroptosis-related genes in laryngeal squamous cell carcinoma6
Comparative study of sarcomatoid carcinoma and carcinosarcoma of the pancreas: a population-based study6
Predictive nomograms for risk and prognostic factors in metastatic bladder cancer: a population-based study6
The efficacy and safety of concurrent chemoradiotherapy with induction chemotherapy vs. concurrent chemoradiotherapy alone for locally advanced nasopharyngeal carcinoma: a systematic-review and meta-a6
A real-world retrospective cohort study: the clinical outcomes and characteristics of platinum-resistant recurrent ovarian cancer6
Constructing a chemokine-based model and identifying CCL17 as a core biomarker associated with immune infiltrates in thyroid cancer6
Sublobar resection is non-inferior to lobectomy in octogenarians and older with stage Ia non-small cell lung cancer6
Construction of a competing endogenous RNA network in head and neck squamous cell carcinoma by pan-cancer analysis6
The peripheral CD4+ T cells predict efficacy in non-small cell lung cancer (NSCLC) patients with the anti-PD-1 treatment6
Erratum: miR-137 represses migration and cell motility by targeting COX-2 in non-small cell lung cancer6
Prognostic and immunological significance of peroxisome proliferator-activated receptor gamma in hepatocellular carcinoma based on multiple databases6
Feasibility and safety of transarterial chemoembolization in patients with liver cancer via the distal radial approach: a single-center retrospective cohort study6
Imaging features of primary mucinous adenocarcinoma of bladder outlet and urethra: a case report and literature review6
Association between family history and prognosis of patients with colorectal cancer: a systematic review and meta-analysis6
Pulmonary metastasis risk and overall survival score in choriocarcinoma: a novel nomogram-based risk assessment system6
Efficacy and safety of chimeric antigen receptor (CAR)-T cell therapy in the treatment of relapsed and refractory multiple myeloma: a systematic-review and meta-analysis of clinical trials6
FLAURA2: evidence for escalated first-line therapy in EGFR-mutated non-small cell lung cancer with central nervous system metastases6
HES1 induces ITPR1-mediated autophagy to exert anti-metastatic effects in pituitary adenomas6
Suppression of hepatocellular carcinoma progression by long noncoding RNA apolipoprotein C1 pseudogene via the regulation of the microRNA-106b-PTEN axis6
Development and validation of a novel ubiquitination-related gene prognostic signature based on tumor microenvironment for colon cancer6
Synergistic action of gemcitabine and celecoxib in promoting the antitumor efficacy of anti-programmed death-1 monoclonal antibody by triggering immunogenic cell death6
Novel hypoxia features with appealing implications in discriminating the prognosis, immune escape and drug responses of 947 hepatocellular carcinoma patients6
Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network based on competitive endogenous RNA in adenoid cystic carcinoma of the salivary gland6
Identification and validation of an immune-related programmed cell death signature for predicting prognosis and immunotherapy in large-scale multicenter cohorts for lung adenocarcinoma6
Retraction: H19/miR-152-3p/TCF4 axis increases chemosensitivity of gastric cancer cells through suppression of epithelial-mesenchymal transition6
Validation of the interaction between PRDX4 and TXNDC5 in gastric cancer and the significance of the PRDX4 gene in gastric cancer based on a data mining analysis6
Identifying epithelial-mesenchymal transition-related genes as prognostic biomarkers and therapeutic targets of hepatocellular carcinoma by integrated analysis of single-cell and bulk-RNA sequencing d6
Preliminary exploration of the potential biological functions and prognosis values of RAB4B in pan-cancer combing with experimental validation in BLCA6
Construction and validation of a nomogram prediction model for predicting the risk of chemotherapy-induced myelosuppression after chemotherapy in patients with triple-negative breast cancer: a single-6
The effects of the tumor suppressor gene PTEN on the proliferation and apoptosis of breast cancer cells via AKT phosphorylation6
Construction of diagnostic and prognostic models based on gene signatures of nasopharyngeal carcinoma by machine learning methods6
Development and validation of a machine learning-based prognostic model using mitochondrial dysfunction-related genes for colorectal cancer patients6
Identification and validation of LINC02381 as a biomarker associated with lymph node metastasis in esophageal squamous cell carcinoma6
Liquid biopsy for the detection of non-viral head and neck squamous cell carcinoma6
Immunogenic cell death-related signature predicts prognosis and immunotherapy efficacy in bladder cancer6
Multimodality treatment for multiple recurrences of cervical cancer after radiotherapy: a case report6
A four-gene signature predicts overall survival of patients with esophageal adenocarcinoma6
Fusobacterium nucleatum and IL-32 co-predict nodal metastasis preoperatively in head and neck cancer6
Correlation of gene expression profiles to identify pancreatic cancer cell lines that best model primary human tumors6
Identification and validation of a necroptosis-related gene prognostic signature for colon adenocarcinoma6
Upregulated YTHDF1 associates with tumor immune microenvironment in head and neck squamous cell carcinomas6
Diagnosis and multimodality treatment of primary malignant tracheal tumors6
Do alkaline phosphatases have great potential in the diagnosis, prognosis, and treatment of tumors?6
Maximal resection for malignant scalp tumors: is it valuable for long-term follow-up?6
Role of 18F-FDG PET/CT in the diagnosis and treatment response assessment of primary pulmonary lymphoma6
Identification and validation of hypoxia-associated genes positively correlated with HIF1A in pulmonary adenocarcinoma6
The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation6
Texture analysis based on PI-RADS 4/5-scored magnetic resonance images combined with machine learning to distinguish benign lesions from prostate cancer6
Analysis of prognostic and therapeutic values of drug resistance-related genes in the lung cancer microenvironment6
Screening of postoperative adjuvant chemotherapy-related serum metabolic markers in breast cancer patients based on 1H NMR metabonomics6
The prognostic value of immune escape-related genes in lung adenocarcinoma6
Comprehensive profiling of cell subsets of gastric cancer and liver metastasis based on single cell RNA-sequencing analysis6
A novel prognostic model based on endoplasmic reticulum stress-associated E3 ligases and deubiquitinating enzymes in hepatocellular carcinoma6
Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes6
Potential added value of computed tomography radiomics to multimodal prediction models for benign and malignant breast tumors6
Survival benefit of adjuvant chemotherapy in elderly patients with stage I triple-negative breast cancer: a cohort study based on the SEER database6
Nomogram for predicting the early death of patients with stage IV ovarian cancer: a retrospective analysis of the SEER database5
Effect of N6-methyladenosine (m6A) regulator-related immunogenes on the prognosis and immune microenvironment of breast cancer5
Screening key prognostic factors and constructing survival prognostic risk prediction model based on ceRNA network in early lung adenocarcinoma5
Clinical characteristics of patients simultaneously diagnosed with lung cancer and active pulmonary tuberculosis in countries where tuberculosis is moderately endemic5
Clinicopathological analysis of primary thyroid non-Hodgkin lymphoma: a single-center study5
The influence of antibody CD166 on the treatment of tumor and the immunological mechanism in mice bearing oral squamous cell carcinoma5
Contribution of sphingomyelin phosphodiesterase acid-like 3B to the proliferation, migration, and invasion of ovarian cancer cells5
Intracranial complete response to toripalimab and anlotinib in a patient with recurrent brain metastases of small cell lung cancer after failure of second-line maintenance therapy: a case report5
Prognostic impact of mitofusin 2 expression in colon cancer5
Nomogram for development and validation of a prognosis prediction model for cancer-specific survival in young breast cancer patients with stage I–III based on the Surveillance, Epidemiology, and End R5
Potential diagnostic marker gene set for non-alcoholic steatohepatitis associated hepatocellular carcinoma with lymphocyte infiltration5
A predictive nomogram for predicting liver metastasis in early-onset colon cancer: a population-based study5
Bioactivity of recombinant humanized monoclonal antibody against HER2 in-vivo and in-vitro and its mechanism of action in ovarian cancer5
Hemicolectomy versus appendectomy alone for appendiceal neuroendocrine tumours between 1–2 cm in size—are we overtreating?5
Comprehensive analysis of necroptosis-related long noncoding RNA to predict prognosis, immune status, and immunotherapeutic response in clear cell renal cell carcinoma5
A EWSR1-CREM-rearranged gastric mesenchymal tumor accompanied by gastritis cystica profunda and with probable benign behavior: a case report5
Study of non-surgical therapeutic patterns and prognosis in elderly patients with stage II non-small-cell lung cancer: an investigational study based on the SEER database5
From induced pluripotent stem cell (iPSC) to universal immune cells: literature review of advances in a new generation of tumor therapies5
Beginning of clinical treatment using the 1.5 Tesla MR-Linac system in Japan: a narrative review5
Integrated bioinformatics investigation of adenylyl cyclase family co-expression network in bladder cancer followed by preliminary validation of member 2 (ADCY2) in tumorigenesis and prognosis5
TFF3 promotes clonogenic survival of colorectal cancer cells through upregulation of EP4 via activation of STAT35
m6A reading protein RBMX as a biomarker for prognosis and tumor progression in esophageal cancer5
In silico development and validation of a novel glucose and lipid metabolism-related gene signature in gastric cancer5
Prognostic factors and clinic-pathologic characteristics of ovarian tumor with different histologic subtypes—a SEER database population study of 41,376 cases5
0.61980295181274